Travere Therapeutics Inc investor relations material

Travere Therapeutics, Inc. is a biopharmaceutical company focused on the identification, development, and commercialization of therapies for the treatment of rare diseases. Travere Therapeutics Inc., are committed to meeting the needs of patients suffering from rare diseases by developing and providing treatments that have the potential to improve their lives. Incorporated in 2008 with a focus on bringing a pathway to approval for people living with these diseases without treatment options, our clinical portfolio includes several ongoing clinical studies in diseases for which there is no approved therapy.